Search details
1.
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
Blood
; 2024 May 10.
Article
in English
| MEDLINE | ID: mdl-38728380
2.
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38577874
3.
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis.
Blood
; 140(12): 1408-1418, 2022 09 22.
Article
in English
| MEDLINE | ID: mdl-35667047
4.
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 2024 Mar 28.
Article
in English
| MEDLINE | ID: mdl-38546696
5.
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
Am J Hematol
; 99(5): 993-996, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38385579
6.
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Eur J Haematol
; 111(2): 181-190, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37082839
7.
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.
Am J Hematol
; 98(1): 112-121, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36266607
8.
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019.
Br J Haematol
; 197(1): 82-96, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35166376
9.
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study.
Haematologica
; 107(5): 1054-1063, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-34162176
10.
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT.
Br J Haematol
; 195(3): 417-428, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34514596
11.
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.
Eur J Haematol
; 106(5): 708-715, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33580608
12.
Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 26(3): 451-457, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31647984
13.
HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis.
Biol Blood Marrow Transplant
; 25(1): 114-120, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30172776
14.
Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2134-2142, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31288095
15.
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2167-2171, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31284069
16.
Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(6): e204-e208, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30930192
17.
Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia.
Br J Haematol
; 185(4): 725-732, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30820933
18.
Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 204(2): 715-718, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38014808
19.
Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis.
Haematologica
; 104(6): 1230-1236, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30655365
20.
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Haematologica
; 109(5): 1608-1613, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38205539